Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.01 SEK | +1.97% | +5.82% | -30.87% |
Feb. 15 | Transcript : Sedana Medical AB, Q4 2023 Earnings Call, Feb 15, 2024 | |
Feb. 15 | Sedana Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 79
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Direct Sales Markets
87.8
%
| 128 | 80.3 % | 108 | 87.8 % | -15.60% |
Distribution Markets
12.2
%
| 31 | 19.7 % | 15 | 12.2 % | -52.09% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Germany
70.1
%
| 109 | 68.3 % | 86 | 70.1 % | -20.79% |
Other Direct Markets
17.4
%
| - | - | 21 | 17.4 % | - |
Distributor Markets
12.2
%
| - | - | 15 | 12.2 % | - |
Sweden
0.3
%
| 1 | 0.4 % | 0 | 0.3 % | -42.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Johannes Doll
CEO | Chief Executive Officer | 43 | 21-09-30 |
Johan Spetz
DFI | Director of Finance/CFO | - | 22-04-03 |
Peter Fröberg
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-10-31 |
Peter Sackey
CTO | Chief Tech/Sci/R&D Officer | 53 | 18-01-07 |
Ron Farrell
CTO | Chief Tech/Sci/R&D Officer | 68 | 00-12-31 |
Director/Board Member | 76 | 04-12-31 | |
Jessica Westfal
IRO | Public Communications Contact | 50 | 19-12-31 |
Stefan Krisch
PRN | Corporate Officer/Principal | 50 | 21-02-28 |
Human Resources Officer | 56 | 20-07-31 | |
Karolina Vilval
LAW | General Counsel | 45 | 22-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 57 | 13-12-31 | |
Hilde Furberg
BRD | Director/Board Member | 65 | 21-12-31 |
Director/Board Member | 49 | 20-05-18 | |
Claus Bjerre
BRD | Director/Board Member | 53 | 21-05-09 |
Director/Board Member | 76 | 04-12-31 | |
Eva Walde
BRD | Director/Board Member | 61 | 17-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 99,336,960 | 62,985,196 ( 63.41 %) | 0 | 63.41 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
- Stock
- Equities
- Stock Sedana Medical AB - Nasdaq Stockholm
- Company Sedana Medical AB